{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:51:12Z","timestamp":1790211072585,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Effusive-constrictive pericarditis (ECP) is a complex clinical condition that combines features of pericardial effusion\/tamponade and constrictive pericarditis. The classic hemodynamic definition is persistent elevation of right atrial pressure despite drainage of a pericardial effusion. This review summarizes recent data on its epidemiology, pathophysiology, diagnosis, and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Prevalence varies from 2.4% to 14.8% depending on diagnostic criteria and etiology, reaching up to 50% in tuberculous pericarditis in endemic regions. Common causes include idiopathic, infectious (particularly tuberculous and bacterial), malignant, and post-surgical etiologies. While invasive hemodynamic assessment remains the reference standard, echocardiography is now the primary diagnostic tool, enabling recognition of constrictive physiology before and after pericardiocentesis. Cardiac magnetic resonance adds complementary information on pericardial thickness, inflammation, and potential for reversibility, aiding therapeutic decisions. Inflammatory ECP frequently resolves with medical therapy (NSAIDs, colchicine, corticosteroids, or IL-1 inhibitors) while tuberculous cases require antimicrobial therapy with corticosteroids in selected patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>ECP is a heterogeneous condition with variable clinical trajectories. Early identification through multimodality imaging is essential to guide therapy, target reversible inflammation, and prevent chronic constriction. Most inflammatory cases respond to anti-inflammatory treatment, whereas pericardiectomy is reserved for persistent, irreversible constrictive physiology despite optimal medical therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11886-025-02326-4","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:23:36Z","timestamp":1768976616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Contemporary Assessment and Management of Effusive-Constrictive Pericarditis"],"prefix":"10.1007","volume":"28","author":[{"given":"Lamis","family":"El Harake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Samhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Al Kazaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"8","key":"2326_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jcmg.2024.04.010","volume":"17","author":"AL Klein","year":"2024","unstructured":"Klein AL, Wang TKM, Cremer PC, et al. Pericardial diseases. JACC Cardiovasc Imaging. 2024;17(8):937\u201388. https:\/\/doi.org\/10.1016\/j.jcmg.2024.04.010.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"2326_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jacc.2024.05.048","volume":"84","author":"M Al-Kazaz","year":"2024","unstructured":"Al-Kazaz M, Klein AL, Oh JK, et al. Pericardial diseases and best practices for pericardiectomy. J Am Coll Cardiol. 2024;84(6):561\u201380. https:\/\/doi.org\/10.1016\/j.jacc.2024.05.048.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2326_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.cpcardiol.2004.03.002","volume":"29","author":"JA Goldstein","year":"2004","unstructured":"Goldstein JA. Cardiac tamponade, constrictive pericarditis, and restrictive cardiomyopathy. Curr Probl Cardiol. 2004;29(9):503\u201367. https:\/\/doi.org\/10.1016\/j.cpcardiol.2004.03.002.","journal-title":"Curr Probl Cardiol"},{"issue":"4","key":"2326_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.pcad.2016.11.001","volume":"59","author":"BD Hoit","year":"2017","unstructured":"Hoit BD. Pathophysiology of the pericardium. Prog Cardiovasc Dis. 2017;59(4):341\u20138. https:\/\/doi.org\/10.1016\/j.pcad.2016.11.001.","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"2326_CR5","first-page":"465","volume":"74","author":"HB Burchell","year":"1954","unstructured":"Burchell HB. Problems in the recognition and treatment of pericarditis. J Lancet. 1954;74(12):465\u201370.","journal-title":"J Lancet"},{"key":"2326_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0002-9149(61)90422-2","volume":"7","author":"P Wood","year":"1961","unstructured":"Wood P. Chronic constrictive pericarditis. Am J Cardiol. 1961;7:48\u201361. https:\/\/doi.org\/10.1016\/0002-9149(61)90422-2.","journal-title":"Am J Cardiol"},{"issue":"2","key":"2326_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/01.cir.43.2.183","volume":"43","author":"EW Hancock","year":"1971","unstructured":"Hancock EW. Subacute effusive-constrictive pericarditis. Circulation. 1971;43(2):183\u201392. https:\/\/doi.org\/10.1161\/01.cir.43.2.183.","journal-title":"Circulation"},{"issue":"5","key":"2326_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1056\/NEJMoa035630","volume":"350","author":"J Sagrist\u00e0-Sauleda","year":"2004","unstructured":"Sagrist\u00e0-Sauleda J, Angel J, S\u00e1nchez A, Permanyer-Miralda G, Soler-Soler J. Effusive-constrictive pericarditis. N Engl J Med. 2004;350(5):469\u201375. https:\/\/doi.org\/10.1056\/NEJMoa035630.","journal-title":"N Engl J Med"},{"issue":"2 Pt 1","key":"2326_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0002-8703(87)90278-x","volume":"113","author":"J Cameron","year":"1987","unstructured":"Cameron J, Oesterle SN, Baldwin JC, Hancock EW. The etiologic spectrum of constrictive pericarditis. Am Heart J. 1987;113(2 Pt 1):354\u201360. https:\/\/doi.org\/10.1016\/0002-8703(87)90278-x.","journal-title":"Am Heart J"},{"issue":"10","key":"2326_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077532","volume":"8","author":"M Ntsekhe","year":"2013","unstructured":"Ntsekhe M, Matthews K, Syed FF, et al. Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion. PLoS One. 2013;8(10):e77532. https:\/\/doi.org\/10.1371\/journal.pone.0077532.","journal-title":"PLoS One"},{"issue":"7","key":"2326_CR11","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/01.cir.94.7.1635","volume":"94","author":"O Nugue","year":"1996","unstructured":"Nugue O, Millaire A, Porte H, et al. Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients. Circulation. 1996;94(7):1635\u201341. https:\/\/doi.org\/10.1161\/01.cir.94.7.1635.","journal-title":"Circulation"},{"issue":"5","key":"2326_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5830\/CVJA-2011-072","volume":"23","author":"M Ntsekhe","year":"2012","unstructured":"Ntsekhe M, Shey Wiysonge C, Commerford PJ, Mayosi BM. The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature. Cardiovasc J Afr. 2012;23(5):281\u20135. https:\/\/doi.org\/10.5830\/CVJA-2011-072.","journal-title":"Cardiovasc J Afr"},{"issue":"21","key":"2326_CR13","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.106.662114","volume":"115","author":"M Imazio","year":"2007","unstructured":"Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115(21):2739\u201344. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.662114.","journal-title":"Circulation"},{"key":"2326_CR14","unstructured":"Reuter H, Burgess LJ, Louw VJ, Doubell AF. The management of tuberculous pericardial effusion: experience in 233 consecutive patients."},{"issue":"4","key":"2326_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/0735-1097(88)90203-3","volume":"11","author":"J Sagrist\u00e0-Sauleda","year":"1988","unstructured":"Sagrist\u00e0-Sauleda J, Permanyer-Miralda G, Soler-Soler J. Tuberculous pericarditis: ten year experience with a prospective protocol for diagnosis and treatment. J Am Coll Cardiol. 1988;11(4):724\u20138. https:\/\/doi.org\/10.1016\/0735-1097(88)90203-3.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2326_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jcmg.2017.06.017","volume":"11","author":"KH Kim","year":"2018","unstructured":"Kim KH, Miranda WR, Sinak LJ, et al. Effusive-Constrictive pericarditis after pericardiocentesis: Incidence, associated Findings, and natural history. JACC Cardiovasc Imaging. 2018;11(4):534\u201341. https:\/\/doi.org\/10.1016\/j.jcmg.2017.06.017.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"2326_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jcmg.2017.10.028","volume":"11","author":"AL Klein","year":"2018","unstructured":"Klein AL, Cremer PC. Ephemeral effusive constrictive pathophysiology\u2217. JACC Cardiovasc Imaging. 2018;11(4):542\u20135. https:\/\/doi.org\/10.1016\/j.jcmg.2017.10.028.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"2326_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccl.2017.07.008","volume":"35","author":"WR Miranda","year":"2017","unstructured":"Miranda WR, Oh JK. Effusive-constrictive pericarditis. Cardiol Clin. 2017;35(4):551\u20138. https:\/\/doi.org\/10.1016\/j.ccl.2017.07.008.","journal-title":"Cardiol Clin"},{"issue":"3","key":"2326_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10741-012-9308-0","volume":"18","author":"FF Syed","year":"2013","unstructured":"Syed FF, Ntsekhe M, Mayosi BM, Oh JK. Effusive-constrictive pericarditis. Heart Fail Rev. 2013;18(3):277\u201387. https:\/\/doi.org\/10.1007\/s10741-012-9308-0.","journal-title":"Heart Fail Rev"},{"key":"2326_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132945","author":"M Imazio","year":"2025","unstructured":"Imazio M, Brucato A, Lazaros G, et al. Outcomes of acute pericarditis with an inflammatory phenotype. Int J Cardiol. 2025. https:\/\/doi.org\/10.1016\/j.ijcard.2024.132945.","journal-title":"Int J Cardiol"},{"issue":"5","key":"2326_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1056\/NEJMp038199","volume":"350","author":"EW Hancock","year":"2004","unstructured":"Hancock EW. A clearer view of effusive-constrictive pericarditis. N Engl J Med. 2004;350(5):435\u20137. https:\/\/doi.org\/10.1056\/NEJMp038199.","journal-title":"N Engl J Med"},{"issue":"17","key":"2326_CR22","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1161\/CIRCULATIONAHA.111.026070","volume":"124","author":"D Feng","year":"2011","unstructured":"Feng D, Glockner J, Kim K, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation. 2011;124(17):1830\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.026070.","journal-title":"Circulation"},{"issue":"3","key":"2326_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4250\/jcu.2009.17.3.102","volume":"17","author":"GM Park","year":"2009","unstructured":"Park GM, Lee JY, Kim YG, et al. Recurrent postoperative effusive-constrictive pericarditis associated with steroid discontinuation. J Cardiovasc Ultrasound. 2009;17(3):102\u20135. https:\/\/doi.org\/10.4250\/jcu.2009.17.3.102.","journal-title":"J Cardiovasc Ultrasound"},{"issue":"4","key":"2326_CR24","first-page":"200","volume":"19","author":"JB Russell","year":"2008","unstructured":"Russell JB, Syed FF, Ntsekhe M, et al. Tuberculous effusive-constrictive pericarditis. Cardiovasc J Afr. 2008;19(4):200\u20131.","journal-title":"Cardiovasc J Afr"},{"issue":"6","key":"2326_CR25","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00246-005-0990-8","volume":"26","author":"N Okamoto","year":"2005","unstructured":"Okamoto N, Shiraishi H, Konishi H, Momoi MY. Effusive\u2013constrictive epicarditis that developed more than 5 years after ventricular septal defect closure: two cases relieved by epicardiectomy. Pediatr Cardiol. 2005;26(6):872\u20136. https:\/\/doi.org\/10.1007\/s00246-005-0990-8.","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"2326_CR26","first-page":"271","volume":"20","author":"N Akhtar","year":"2010","unstructured":"Akhtar N, Khalid A, Ahmed W, Rasheed K. Rapidly progressive effusive constrictive pericarditis caused by methicillin sensitive Staphylococcus aureus (MSSA). samraakhtar@hotmail.com. J Coll Physicians Surg\u2013Pak JCPSP. 2010;20(4):271\u20133.","journal-title":"J Coll Physicians Surg\u2013Pak JCPSP"},{"key":"2326_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv318","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015. https:\/\/doi.org\/10.1093\/eurheartj\/ehv318.","journal-title":"Eur Heart J"},{"issue":"3","key":"2326_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/CIRCIMAGING.113.001613","volume":"7","author":"TD Welch","year":"2014","unstructured":"Welch TD, Ling LH, Espinosa RE, et al. Echocardiographic diagnosis of constrictive pericarditis: Mayo clinic criteria. Circ Cardiovasc Imaging. 2014;7(3):526\u201334. https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.001613.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2326_CR29","doi-asserted-by":"publisher","unstructured":"Miranda WR, Newman DB, Oh JK. Effusive-Constrictive pericarditis: doppler findings. Curr Cardiol Rep. 2019;21(11). https:\/\/doi.org\/10.1007\/s11886-019-1243-4.","DOI":"10.1007\/s11886-019-1243-4"},{"issue":"4","key":"2326_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4250\/jcu.2016.24.4.317","volume":"24","author":"P van der Bijl","year":"2016","unstructured":"van der Bijl P, Herbst P, Doubell AF. Redefining effusive-constrictive pericarditis with echocardiography. J Cardiovasc Ultrasound. 2016;24(4):317\u201323. https:\/\/doi.org\/10.4250\/jcu.2016.24.4.317.","journal-title":"J Cardiovasc Ultrasound"},{"issue":"5","key":"2326_CR31","doi-asserted-by":"publisher","first-page":"e003125","DOI":"10.1161\/CIRCIMAGING.114.003125","volume":"8","author":"PC Cremer","year":"2015","unstructured":"Cremer PC, Tariq MU, Karwa A, et al. Quantitative assessment of pericardial delayed hyperenhancement predicts clinical improvement in patients with constrictive pericarditis treated with anti-inflammatory therapy. Circ Cardiovasc Imaging. 2015;8(5):e003125. https:\/\/doi.org\/10.1161\/CIRCIMAGING.114.003125.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"2326_CR32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/hrt.2005.072348","volume":"92","author":"JW Ha","year":"2006","unstructured":"Ha JW, Ko YG, Choi BW. Images in cardiology. Delayed hyperenhancement of the pericardium by magnetic resonance imaging as a marker of pericardial inflammation in a patient with tuberculous effusive constrictive pericarditis. Heart Br Card Soc. 2006;92(4):494. https:\/\/doi.org\/10.1136\/hrt.2005.072348.","journal-title":"Heart Br Card Soc"},{"issue":"3","key":"2326_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/s0730-725x(97)00296-8","volume":"16","author":"A Watanabe","year":"1998","unstructured":"Watanabe A, Hara Y, Hamada M, et al. A case of effusive-constructive pericarditis: an efficacy of GD-DTPA enhanced magnetic resonance imaging to detect a pericardial thickening. Magn Reson Imaging. 1998;16(3):347\u201350. https:\/\/doi.org\/10.1016\/s0730-725x(97)00296-8.","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"2326_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.007059","volume":"11","author":"ICY Chang","year":"2018","unstructured":"Chang ICY, Bois JP, Bois MC, Maleszewski JJ, Johnson GB, Grogan M. Hydroxychloroquine-mediated cardiotoxicity with a false-positive99m technetium\u2013labeled pyrophosphate scan for transthyretin-related cardiac amyloidosis. Circ Cardiovasc Imaging. 2018;11(1):e007059. https:\/\/doi.org\/10.1161\/CIRCIMAGING.117.007059.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"23","key":"2326_CR35","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1161\/CIRCULATIONAHA.105.543066","volume":"112","author":"BM Mayosi","year":"2005","unstructured":"Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112(23):3608\u201316. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.543066.","journal-title":"Circulation"},{"issue":"9","key":"2326_CR36","doi-asserted-by":"publisher","first-page":"CD000526","DOI":"10.1002\/14651858.CD000526.pub2","volume":"2017","author":"CS Wiysonge","year":"2017","unstructured":"Wiysonge CS, Ntsekhe M, Thabane L, et al. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev. 2017;2017(9):CD000526. https:\/\/doi.org\/10.1002\/14651858.CD000526.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8573","key":"2326_CR37","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/s0140-6736(87)91127-5","volume":"2","author":"JI Strang","year":"1987","unstructured":"Strang JI, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet Lond Engl. 1987;2(8573):1418\u201322. https:\/\/doi.org\/10.1016\/s0140-6736(87)91127-5.","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"2326_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.5588\/ijtld.17.0341","volume":"22","author":"IA George","year":"2018","unstructured":"George IA, Thomas B, Sadhu JS. Systematic review and meta-analysis of adjunctive corticosteroids in the treatment of tuberculous pericarditis. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2018;22(5):551\u20136. https:\/\/doi.org\/10.5588\/ijtld.17.0341.","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"issue":"12","key":"2326_CR39","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMoa1407380","volume":"371","author":"BM Mayosi","year":"2014","unstructured":"Mayosi BM, Ntsekhe M, Bosch J, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 2014;371(12):1121\u201330. https:\/\/doi.org\/10.1056\/NEJMoa1407380.","journal-title":"N Engl J Med"},{"key":"2326_CR40","doi-asserted-by":"publisher","unstructured":"Wang TKM, Klein AL, Cremer PC et al. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis. JACC. 0(0). https:\/\/doi.org\/10.1016\/j.jacc.2025.05.023","DOI":"10.1016\/j.jacc.2025.05.023"},{"issue":"2","key":"2326_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/0218492311399496","volume":"19","author":"N Yamamoto","year":"2011","unstructured":"Yamamoto N, Ohara K, Nie M, Torii S, Inoue N, Miyaji K. For what type of constrictive pericarditis is the waffle procedure effective? Asian Cardiovasc Thorac Ann. 2011;19(2):115\u20138. https:\/\/doi.org\/10.1177\/0218492311399496.","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"5","key":"2326_CR42","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/s0003-4975(10)60693-5","volume":"36","author":"RO Heimbecker","year":"1983","unstructured":"Heimbecker RO, Smith D, Shimizu S, Kestle J. Surgical technique for the management of constrictive epicarditis complicating constrictive pericarditis (the waffle procedure). Ann Thorac Surg. 1983;36(5):605\u20136. https:\/\/doi.org\/10.1016\/s0003-4975(10)60693-5.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"2326_CR43","first-page":"643","volume":"42","author":"CL Kao","year":"2001","unstructured":"Kao CL, Chang JP. Modified method for epicardial constriction: the electric-Waffle procedure. J Cardiovasc Surg (Torino). 2001;42(5):643\u20136.","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"10","key":"2326_CR44","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/j.1540-8175.2007.00505.x","volume":"24","author":"B Zagol","year":"2007","unstructured":"Zagol B, Minderman D, Munir A, D\u2019Cruz I. Effusive constrictive pericarditis: 2D, 3D echocardiography and MRI imaging. Echocardiogr Mt Kisco N. 2007;24(10):1110\u20134. https:\/\/doi.org\/10.1111\/j.1540-8175.2007.00505.x.","journal-title":"Echocardiogr Mt Kisco N"},{"issue":"Supplement1","key":"2326_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae666.2103","volume":"45","author":"PC Cremer","year":"2024","unstructured":"Cremer PC, Garshick M, Luis SA, et al. Increased adoption of IL-1 pathway inhibition and the steroid-sparing paradigm shift: temporal trends in recurrent pericarditis treatment from the RESONANCE patient registry. Eur Heart J. 2024;45(Supplement1):ehae6662103. https:\/\/doi.org\/10.1093\/eurheartj\/ehae666.2103.","journal-title":"Eur Heart J"},{"issue":"2","key":"2326_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jacbts.2020.11.016","volume":"6","author":"AG Mauro","year":"2021","unstructured":"Mauro AG, Bonaventura A, Vecchi\u00e9 A, et al. The role of NLRP3 inflammasome in pericarditis. JACC: Basic to Translational Science. 2021;6(2):137\u201350. https:\/\/doi.org\/10.1016\/j.jacbts.2020.11.016.","journal-title":"JACC: Basic to Translational Science"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-025-02326-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-025-02326-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-025-02326-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:53:46Z","timestamp":1781628826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-025-02326-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2326"],"URL":"https:\/\/doi.org\/10.1007\/s11886-025-02326-4","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lamis El Harake has no disclosures to report. Ashraf Samhan has no disclosures to report. Al-Kazaz: Research grants from Kiniksa Pharmaceuticals, Ventyx BioSciences, and Cardiol Therapeutics; speaking honoraria from Kiniksa Pharmaceuticals; and consulting fees from Edwards Lifesciences. Cremer: Consulting fees from Kiniksa Pharmaceuticals, CardiolRx, Ventyx Biosciences, Monte Rosa Therapuetics, Pfizer, Boston Scientific, and General Electric.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13"}}